Diana Brainard
2021
In 2021, Diana Brainard earned a total compensation of $15.1M as Chief Executive Officer at Allovir.
Compensation breakdown
| Non-Equity Incentive Plan | $350,400 |
|---|---|
| Option Awards | $9,085,643 |
| Salary | $365,000 |
| Stock Awards | $4,748,000 |
| Other | $587,078 |
| Total | $15,136,121 |
Brainard received $9.1M in option awards, accounting for 60% of the total pay in 2021.
Brainard also received $350.4K in non-equity incentive plan, $365K in salary, $4.7M in stock awards and $587.1K in other compensation.
Rankings
In 2021, Diana Brainard's compensation ranked 529th out of 12,415 executives tracked by ExecPay. In other words, Brainard earned more than 95.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 529 out of 12,415 | 96th |
Division Manufacturing | 176 out of 5,505 | 97th |
Major group Chemicals And Allied Products | 55 out of 2,375 | 98th |
Industry group Drugs | 50 out of 2,096 | 98th |
Industry Biological Products, Except Diagnostic Substances | 19 out of 449 | 96th |
Source: SEC filing on April 6, 2022.
Brainard's colleagues
We found four more compensation records of executives who worked with Diana Brainard at Allovir in 2021.